These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33631204)

  • 1. Ca
    Khelashvili G; Plante A; Doktorova M; Weinstein H
    Biophys J; 2021 Mar; 120(6):1105-1119. PubMed ID: 33631204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ca
    Khelashvili G; Plante A; Doktorova M; Weinstein H
    bioRxiv; 2021 Jan; ():. PubMed ID: 33299996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca
    Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Fusion Peptide has a Greater Membrane Perturbating Effect than SARS-CoV with Highly Specific Dependence on Ca
    Lai AL; Freed JH
    J Mol Biol; 2021 May; 433(10):166946. PubMed ID: 33744314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding mode of SARS-CoV-2 fusion peptide to human cellular membrane.
    Gorgun D; Lihan M; Kapoor K; Tajkhorshid E
    Biophys J; 2021 Jul; 120(14):2914-2926. PubMed ID: 33675757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane.
    Schaefer SL; Jung H; Hummer G
    J Phys Chem B; 2021 Jul; 125(28):7732-7741. PubMed ID: 34255499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical Negatively Charged Residues Are Important for the Activity of SARS-CoV-1 and SARS-CoV-2 Fusion Peptides.
    Lai AL; Freed JH
    bioRxiv; 2021 Dec; ():. PubMed ID: 34909776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negatively charged residues in the membrane ordering activity of SARS-CoV-1 and -2 fusion peptides.
    Lai AL; Freed JH
    Biophys J; 2022 Jan; 121(2):207-227. PubMed ID: 34929193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner.
    Lai AL; Millet JK; Daniel S; Freed JH; Whittaker GR
    J Mol Biol; 2017 Dec; 429(24):3875-3892. PubMed ID: 29056462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membranotropic and biological activities of the membrane fusion peptides from SARS-CoV spike glycoprotein: The importance of the complete internal fusion peptide domain.
    Basso LGM; Zeraik AE; Felizatti AP; Costa-Filho AJ
    Biochim Biophys Acta Biomembr; 2021 Nov; 1863(11):183697. PubMed ID: 34274319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Distinct Structural Features of the SARS-CoV-2 Spike Protein Fusion Domain Essential for Membrane Interaction.
    Birtles D; Lee J
    Biochemistry; 2021 Oct; 60(40):2978-2986. PubMed ID: 34570469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Binding Modes of SARS-CoV-1 and SARS-CoV-2 Fusion Peptides to Cell Membranes: The Influence of Peptide Helix Length.
    Shen H; Wu Z; Chen L
    J Phys Chem B; 2022 Jun; ():. PubMed ID: 35658454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Terminal Lipidation of SARS-CoV-2 Fusion Peptide Reinstates Superior Membrane Fusion Catalytic Ability.
    Sardar A; Bera T; Kumar Samal S; Dewangan N; Kamble M; Guha S; Tarafdar PK
    Chemistry; 2023 Feb; 29(10):e202203034. PubMed ID: 36422064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2.
    Williams-Noonan BJ; Todorova N; Kulkarni K; Aguilar MI; Yarovsky I
    J Phys Chem B; 2021 Mar; 125(10):2533-2550. PubMed ID: 33657325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
    Pal D
    J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes.
    Guillén J; de Almeida RF; Prieto M; Villalaín J
    J Phys Chem B; 2008 Jun; 112(23):6997-7007. PubMed ID: 18489147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane structure of the human immunodeficiency virus gp41 fusion peptide by molecular dynamics simulation. II. The glycine mutants.
    Wong TC
    Biochim Biophys Acta; 2003 Jan; 1609(1):45-54. PubMed ID: 12507757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
    Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
    Elife; 2020 Oct; 9():. PubMed ID: 33103998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of SARS-CoV-2 and MERS-CoV fusion peptides measured using single-molecule force methods.
    Qiu C; Whittaker GR; Gellman SH; Daniel S; Abbott NL
    Biophys J; 2023 Feb; 122(4):646-660. PubMed ID: 36650897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Insight Into the Mechanism of SARS-CoV-2 Membrane Fusion.
    Borkotoky S; Dey D; Banerjee M
    J Chem Inf Model; 2021 Jan; 61(1):423-431. PubMed ID: 33412850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.